PMD Psychemedics Earnings per share trend in current year

Official company branding of Psychemedics Inc (PMD)

Cannabis legalization risks and rapid tests are weighing on revenue, causing year-over-year EPS shifts to reflect current volatility. The -274.90 level indicates the status of the profit parameter. Psychemedics (PMD) bases its business foundation on leadership in high-precision hair analysis, while operational activities are strictly limited by FDA regulations regarding the disposal of biomaterials.

PMD Psychemedics Net earnings per share growth this year (07/04/2022 - 12/21/2024)

Financial and market metric breakdowns for Psychemedics (PMD)

- current quotes and average value forecast:
Market Chart Psychemedics Corp.|PMD - Price Target Chart
- market capitalization data:
Market Valuation Psychemedics Inc|PMD - Total Company Value
- issuer book value statistics:
Net Assets per Share Psychemedics|PMD - Company Net Assets|Market-to-Book Ratio psychemedics.com|PMD - Company Total Assets
- debt and liquidity details:
Total Debt to Equity Ratio Psychemedics|PMD - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital psychemedics.com|PMD - Company Aggregate Debts|Debts to Book Value Psychemedics Inc|PMD - Company Long-Term Debt|Company Current Liabilities Psychemedics|Immediate Liquidity psychemedics.com
- earnings and multiples data:
PMD - Net Profit|Net Profit Forecast Psychemedics|PMD - P/E Multiple|Market Cap to Projected Earnings Psychemedics Inc|PMD - PEG Multiple|Enterprise Value to EBITDA Ratio Psychemedics Inc|PMD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Psychemedics|PMD - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months psychemedics.com|PMD - Earnings per share growth in current year|Expected earnings per share growth for next year Psychemedics
Fundamental valuation:PMD Psychemedics Corp.
Core merchandise of psychemedics.com

Stable subscriptions from Psychemedics (PMD) for laboratory tests provided to courts and corporations directly drive the dynamics of the annual EPS range. This indicator measures the percentage shift in earnings per share relative to the previous year, revealing the business's actual resilience to market shocks. While the positive trajectory confirms the effectiveness of the diversification strategy, the sharp growth requires a comparison with multiples to avoid overpaying for the asset.

Main competitors

A - Expected net earnings per share growth this year|Earnings per share growth in current year Quest|Illumina Platform - Earnings per share trend in current year|Earnings per share growth in current year Exact Sciences (EXAS)|Expected net earnings per share growth this year revvity.com|Bio-Rad - Net earnings per share growth this year|Anbio Biotechnology Ltd (NNNN) - Earnings per share growth rate in current year|Sterigenics - Earnings growth in current year|QuidelOrtho Inc. (QDEL) - Net earnings per share growth this year|OPK: Earnings growth in current year|CareDx - Earnings per share increase in current year|MRVI (Maravai LifeSciences Holdings, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Fulgent Genetics Inc FLGT|Earnings per share growth in current year Fluidigm (LAB)|Net earnings per share growth this year Cytek Corp CTKB|Earnings growth in current year OSUR (OraSure Technologies)|Exagen Inc (XGN) - Earnings per share growth rate in current year|MDxHealth - Earnings growth in current year|LUCD (Lucid Diagnostics, Inc.) - Earnings per share growth this year|PRE: Earnings growth in current year|IMDX - Expected net earnings per share growth this year|TRIB (Trinity Biotech PLC) - Earnings growth in current year|Net earnings per share growth this year prophaselabs.com (PRPH)|Earnings per share growth in current year Ainos (AIMD)|Expected net earnings per share growth this year Co-Diagnostics Inc|Earnings per share growth in current year Heart Test Laboratories Inc. HSCS|BMRA (Biomerica Inc) - Earnings per share trend in current year|CDIO - Earnings per share growth in current year|onconetix.gcs-web.com (ONCO) - Net earnings per share growth this year|VRAX: Earnings growth in current year|Earnings per share growth this year BJDX|Earnings per share growth in current year Vermillion|Net earnings per share growth this year Accelerate Diagnostics Inc (AXDX)|Earnings growth in current year CNTG|ENZ - Earnings per share growth rate in current year|Earnings growth in current year FRES (Fresh2 Group)|GENE: Earnings per share growth this year|23andMe Inc. - Earnings growth in current year